Phase I, Open-Label, Pharmacokinetic, Dose Escalation Study of Carisbamate in Adult and Pediatric Subjects with Lennox-Gastaut Syndrome

Administered By

Awarded By

Contributors

Start/End

  • October 31, 2019 - August 31, 2022